Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes
Jesús Rivera-Esteban; Mònica Pons; Alejandra Planas; Ramiro Manzano-Nuñez; Cristina Hernández; Olga Simó-Servat; Jordi Bañeras; María José Soler; Daniel Seron; Anna Boixadera; Salvador Augustin; Rafael Simó; Ignacio Ferreira-González; Joan Genescà; Juan M. Pericàs;
Gastroenterol Hepatol. 2023;46:682-91
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study
Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;
Gastroenterol Hepatol. 2024;47:463-72
GATA3 promotes the autophagy and activation of hepatic stellate cell in hepatic fibrosis via regulating miR-370/HMGB1 pathway
Zhengyuan Xie; Yangyang Li; Peiguang Xiao; Shanmiao Ke;
Gastroenterol Hepatol. 2024;47:219-29